Definitive Contract HHSN268201600042C
Award Date 9/26/16
Potential Completion Date 9/25/19
Potential Value $3M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Partial Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Andover, MA 01810, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, to develop a Transcatheter Cavopulmonary Bypass Endograft (TCBE) device for treating congenital heart disease. The potential value of the contract is $440,000.00. Transmural Systems has previously worked on various catheter-based cardiovascular devices under past federal...
- This is a $3,412,128 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for Phase I of a Fast-Track Small Business Innovation Research (SBIR) award focused on "Devices for Transcatheter Surgery". The original solicitation was part of the NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small...
- This is a federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Transmural Systems LLC, a woman-owned small business. The $3,232,374.00 Firm Fixed Price contract is for the development of a "Device System for Transcatheter Repair of Postinfarction Ventricular Septal Defect" under the Small Business Innovation Research (SBIR) Fast-Track program. The contract has a period of performance through December 31, 2024. Transmural Systems has...
- The National Heart, Lung, and Blood Institute awarded a $399,352 Small Business Innovation Research (SBIR) Phase I contract to Transmural Systems LLC, a woman-owned small business specializing in cardiovascular medical device development. The contract, awarded on September 16, 2019, focuses on the development of a transcatheter Potts shunt device and is designated as a Total Small Business set-aside. The work will be performed in Andover, Massachusetts under a firm fixed-price contract...
- This is a $2,297,559.00 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Transmural Systems LLC, a woman-owned small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, with a Topic 106 FAST-TRACK designation, for the development of an Active MRI Needle. Transmural Systems has previously received SBIR awards and grants from the National Institutes of Health and National Heart, Lung, and Blood...
- This is a $3,299,988.00 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I research project on a "CERCLAGE FOR TREATING SECONDARY MITRAL REGURGITATION". The contract was set aside for total small business participation and has an ultimate completion date of June 30,...
- This definitive contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Transmural Systems LLC. The $399,924 firm fixed price contract is for Phase I research under Solicitation A, which sought Small Business Innovation Research (SBIR) proposals in support of NIH and Centers for Disease Control and Prevention (CDC) agency missions. Specifically, Transmural Systems will conduct research and development of a transcatheter...
- This is a $3,399,609 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for research and development of an "Intramyocardial Suture Annuloplasty System" under the NIH's Small Business Innovation Research (SBIR) program. This contract was set aside for total small business participation. Through past SBIR awards,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2.2 million firm fixed-price contract to Transmural Systems LLC, a woman-owned small business based in Andover, Massachusetts, to develop tapered guidewires for transcatheter electrosurgery under the Small Business Innovation Research (SBIR) program. This Fast-Track award, designated as a partial small business set-aside, was issued on September 21, 2018, with an ultimate completion date of June 30, 2022. The contract supports...
- The National Heart Lung and Blood Institute awarded a purchase order to Transmural Systems LLC, a woman-owned small business, for active MRI guidewire development with a ceiling value of $1.1 million and an award date of September 28, 2018. The order carries a total small business set-aside. Place of performance is Bethesda, Maryland. The ultimate completion date was November 30, 2020. In fiscal year 2021, the order invoiced $750 thousand across 1.9 FTEs and 3,851 contractor hours, yielding a...
This is a federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Transmural Systems LLC, a woman-owned small business. The $2,999,984 Firm Fixed Price contract is for the development of a Transcatheter Cavopulmonary Bypass Endograft, which is a medical device to treat congenital heart disease. This contract was awarded as a Direct to Phase II Small Business Innovation Research (SBIR) project, indicating it builds upon prior SBIR-funded research and development work by Transmural Systems in the area of catheter-based cardiovascular devices. The contract has a period of performance through September 2019 and is set aside for small business participation.
Generated 12/3/24, 9:50 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 2/3 | 9/19/16, 11:34 AM | |
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS - PHS-2016-1 | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 3/3 | 9/19/16, 11:42 AM | |
A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 1/3 | 7/2/15, 3:21 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 12/2/24 | |
| Not listed | Not listed | $3.0m | 9/26/16 |